Nuclear medicine firm Digirad posted a double-digit increase in sales and swung into the black for its 2014 second quarter (end-June 30).
The company posted revenues of $14.6 million for the quarter, up 13% from revenues of $12.9 million in the same period a year ago. Net income, which included $100,000 in restructuring costs related to a previously announced lease termination, was $823,000, compared with a net loss of $616,000 in the same quarter last year, Digirad said.
Meanwhile, revenues in diagnostic imaging dropped slightly to $3.2 million, compared with $3.4 million in the same quarter of 2013. The company attributed the decline to the timing and volume of cameras sold each quarter. Still, it continues to be on track to grow its diagnostic services business, Digirad said.
